In a prospective surveillance study (February 1990-December 1991 performed at a 1000-bed teaching hospital to identify risk factors for nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, 309 patients were found to be colonized (n = 103; 33 %) or infected (n = 206; 67 %) by MRSA. Sixty-three of them developed bacteremia. Compared with 114 patients who had nosocomial bacteremia caused by methiciilin-sensitive Staphylococcus aureus during the same period of time, MRSA baeteremic patients had more severe underlying diseases (p < 0.01), were more often in intensive care units (p < 0.01) and had received prior antibiotic therapy more frequently (p < 0.01). To further identify risk factors for MRSA bacteremia, univariate and multivariate analyses of this series of 309 patients were performed using the occurrence of MRSA bacteremia as the dependent variable. Among 14 variables analyzed, intravascular catheterization, defined as one or more intravascular catheters in place for more than 48 h, was the only variable selected by a logistic regression model as an independent risk factor (OR = 2.7, CI = 1.1-6.6). The results of this study reinforce the concept that recent antibiotic therapy may predispose patients to MRSA infection and suggest that among patients colonized or infected by MRSA, those with intravascular catheters are at high risk of developing MRSA bacteremia.
Since 1989 (1, 2) methicillin-resistant Staphylococcus aureus (MRSA) has been detected in the majority of Spanish tertiary hospitals as a microorganism responsible for an increasing number of nosocomia] staphylococcal infections. The introduction of an epidemic strain in our hospital at the end of 1989 resulted in a large outbreak of infections. Between February 1990 and December 1991, we prospectively identified all patients with MRSA colonization or infection, using a specific protocol. One of the most striking clinical observations was that 30 % of infected patients had MRSA bacteremia. As we were concerned about the relevance of bloodstream infections in this population, we performed the present study to determine the risk factors for development of nosocomial MRSA bacteremia among hospitalized patients with MRSA colonization or infection.
l Infectious Disease Service, and 2Microbiology Service, Hospital de Bellvitge, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Patients and Methods
Setth~g. Hospital de Bellvitge is a 1,000-bed teaching hospital for adult patients in the Barcelona area which provides acute medical and surgical care, excluding pediatrics, obstetrics and burns. Our hospital has five intensive care units (ICUs) with 60 beds and an active organ transplant program. Yearly admittance is about 22,000 patients.
blfection Control Policy. A bloodstream infection surveillance program has been carried out in our hospital since 1984. All patients with bacteremia identified daily at our microbiology laboratory are visited by an infectious diseases physician who fills out a computer-assisted protocol and provides medical advice when indicated. An active MRSA infection control program was introduced in 1990 after the detection of initial isolates. The program involves identification and isolation of all patients with MRSA colonization or infection, use of nasal mupirocin for health care workers and patients, and reinforcement of careful handwashing and educational programs throughout the hospital. Cases are identified by daily laboratory surveillance of positive cultures, screening of the roommate in sporadic cases, screening of the ward when a cluster of cases occurs, and detection of rehospitalized patients with previous MRSA. All MRSA infected or colonized patients are visited by one of the authors and included in a computer-assisted surveillance protocol. Susceptibility to oxacillin was tested by disk diffusion and microbroth dilution methods. For the disk diffusion test, a 1 ~tg oxacillin disk and standard zone size criteria were used (6). Other antibiotics tested by disk diffusion methods were gentamicin, erythromycin, tetracycline, clindamycin, rifampin, ciprofloxaein, chloramphenicol, trimethoprim/sulfamethoxazole, vancomycin, fosfomycin, mupirocin and fusidic acid. The minimum inhibitory concentration (M/C) was determined by commercial plates (Pos Combo Panel 4I; MicroScan, USA), with two oxacillin dilution wells of 1 lag/ml and 2 ~ag/ml, supplemented with 2 % NaCI. The microdilution trays were inoculated with an inoculum of 10 s cfu/ml and incubated at 35 *C for 24 h. Using NCCLS criteria, the organism was considered resistant to oxacillin if the MIC was greater than 2 ~g/ml.
Bacteriophage typing was performed by the Reference Laboratory (Ccntro Nacional de Microbiologfa de Majadahonda Madrid) using standard methods (7) The incidence of new cases subsided during 1992, and at present the outbreak has been partially controlled. Nevertheless, MRSA has become endemic in two of our ICUs, with a current incidence of around ten cases per month, most of them being mucocutaneous colonization.
The antibiotic susceptibility patterns of the MRSA strains indicated resistance to methicillin, aminoglycosides, erythromycin, rifampin, ciprofloxacin and imipenem, and susceptibility to chloramphenicol, trimethoprim/sulfamethoxazole, vancomycin, teicoplanin, fosfomycin, mupirocin and fusidic acid. Phage typing was performed in 135 isolates. According to the International Phages Set, 25 isolates of MRSA belonged to phage Group III, two isolates to phage Group I, and eight isolates were lysed with phages of phage Groups I and III. One hundred isolates were nontypeable. Plasmid pattern profiles studied in 40 isolates showed a single plasmid (2), suggesting a unique epidemic strain as the to surgery, prior antibiotic therapy, prior ICU setting, administration of total parenteral nutrition, mechanical ventilation and tracheostomy. A more detailed analysis of previous antibiotic therapy showed notable differences between the administration of beta-lactams, aminoglycosides and quinolones, and other antibiotics. However, there were no significant differences in age, sources of infection (except mediastinitis), intravascular devices in place, and outcome between the two groups.
Risk Factors for MRSA Bacteremia.
The univarlate analysis of risk factors for development of bacteremia (Table 3 ) among 309 patients with MRSA infection or colonization selected prior ICU setting, presence of tracheostomy, prior or current administration of total parenteral nutrition, and intravascular catheterization as statistically significant factors. Non-significant variables were age, sex, underlying disease, prior antibiotic therapy, intubation, urinary catheter, decubitus ulcers and source of infection. Unconditional logistic regression analysis using MRSA bacteremia
Discussion
The major epidemiological features of our outbreak did not differ significantly from those of other outbreaks (9-11). The outbreak was focused in the ICUs, with sporadic clusters occurring in the surgical wards. In only a few cases did MRSA acquisition occur in the operating room, linked with the detection of nasal carriers among the surgical team. Besides colonized patients and health care workers, the inanimate hospital environment appeared to be, in our experience, an important hospital reservoir of MRSA, as described previously (9, 12, 13) . It is noteworthy that in one of our ICUs, cultures of gloves worn for purposes of universal precautions after environmental contact and before any contact with patients were positive for MRSA. However, regarding the experience of other authors, the current relevance of environmental contamination may be considered controversial.
A long interval from hospital admission to MRSA acquisition was characteristic, with a mean of 29.4 days. Prior administration of antibiotic therapy was also very frequent. The role of 
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antibiotics in the selection of resistant strains and in Cross-colonization appears to be relevant, but mechanisms have not yet been well established.
Anterior nares and the respiratory tract in intubated patients were the most frequent sites of Colonization. It should be noted that nasogastric tubes did not permit the use of mupirocin in these cases (14) . The clinical spectrum and sites of our patients' infections were in accordance with their Underlying diseases and clinical characteristics. An observation of major concern was the high incidence of patients with MRSA bacteremia. In OUr opinion the 30 % incidence of bacteremia observed among the entire MRSA infected population, similar to that reported by Peacock et al. (15) , is higher than that among hospitalized Patients harboring MSSA or gram-negative bacilli. Nevertheless, this hypothesis is difficult to assess due to the lack of knowledge of the entire population at risk infected with MSSA or gramnegative bacilli.
In contrast to some previous reports (9, 16) , the data from our surveillance program of all bloodStream infections clearly showed that MRSA isolates did not simply replace MSSA, but rather emerged as a distinct microorganism, increasing the total number of cases of staphylococcal bacteremia. This observation, of marked epidemiological interest, has been made by Boyce et al. and Wenzel et al. in both bacteremic and nonbacteremic patients (17, 18) .
The comparison between patients with nosocomial bacteremia due to MRSA and patients with nosocomial bacteremia due to MSSA revealed that both groups had important epidemiological differences, but they did not differ in clinical features and outcome (19) (20) (21) . Epidemiological factors differentiating MRSA and MSSA bacteremic patients were similar to those described as risk factors for acquiring MRSA colonization or infection among the hospital population (22, 23) .
A large number of episodes of staphylococcal bacteremia were defined as primary bacteremia in both groups (MRSA 71.6 % and MSSA 74.6 %), and the majority of them were catheter-related, as ~as previously been reported by others (19, 20, 22, 24) . It remains uncertain whether MRSA differs from MSSA in its intrinsic ability to cause catheter-related infections. Nevertheless, taking into aCCount that the number of patients colonized by MSSA should be greater than those colonized by MRSA, it may be possible that MRSA strains °~Sess a greater capacity to progress to infection In a colonized state. Again, this impression is difficult to assess, because we do not know the number of MSSA colonized patients in theentire hospital.
A major difference between susceptible and resistant strains was the previous administration of antibiotics. Besides the beta-lactams and aminoglycosides, whose role has been previously emphasized in the literature (25) , it is important to point out the potential role of quinolones as a risk factor for selecting MRSA strains, since these antibiotics are being widely used in critical care units.
Risk factors for the development of MRSA bacteremia among colonized or infected patients have not been established in previous reports. Although the univariate analysis identified several variables associated with the development of MRSA bacteremia in our series of patients, the only variable selected by the logistic regression model as an independent risk factor was intravascular catheterization. This data suggests that colonized patients with one or more intravascular catheters in place are at high risk of developing bacteremia. This risk is perhaps higher than that of those colonized by MSSA or by other nosocomial pathogens. It is possible that MRSA strains possess a unique ability to adhere to intravascular devices and other prosthetic materials, but this hypothesis should be proven in prospective studies.
Recent data show that MRSA strains are at least equally as pathogenic as susceptible strains (26) and might be even more virulent (27) , although more studies are needed to confirm this finding.
Nevertheless, the relationship between virulence, spread and adherence is difficult to elucidate, and the factors that influence colonization and adherence, as well as the role of extracellular toxins and enzymes, should be further clarified (28) . In conclusion, the main risk factors for nosocomial MRSA bacteremia identified in our study are similar to those described for MRSA colonization elsewhere. Recent antibiotic therapy, including treatment with the new quinolones, seems to play a major role. Among patients colonized or infected by MRSA, those with intravascular devices are at very high risk of developing MRSA bacteremia.
